Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
329.00    0.00 (0.00%)
Bid:
322.00
Ask:
336.00
Spread: 14.00 (4.348%)
Market Cap: £41.75m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Share Buyback

31 Mar 2016 07:20

RNS Number : 6564T
BrainJuicer Group PLC
31 March 2016
 

 

 

 

Press Release

31 March 2016

 

BrainJuicer Group PLC (AIM: BJU)

("BrainJuicer" or "the Company")

 

Share Buyback

 

BrainJuicer, the innovative international market research agency, is pleased to announce its intention to commence, with immediate effect, a share buy-back (the "Buyback") using existing cash resources to make market purchases of up to 1 million of its ordinary shares pursuant to the general authority given to it at the Company's 2015 Annual General Meeting.

 

Following the full year results announcement on Monday 21 March 2016, and the recent weakness in the share price, and in line with the stated commitment to return excess capital to shareholders, the Board has decided to implement the Buyback. Accordingly, any shareholders wishing to participate in the Buyback should contact the Company's broker Canaccord Genuity Limited. The Buyback shall be effected in such manner and on such terms as the directors of the Company may from time to time determine.

 

The maximum price to be paid shall not be more than the higher of: (i) 5% above the average middle market closing price of the Company's shares for the 5 business days immediately preceding the day on which the purchase is made; and (ii) that stipulated by article 5(1) of the Buyback and Stabilisation Regulation.

 

The Buyback will be undertaken until the earlier of all 1 million ordinary shares being repurchased and the Company's 2016 Annual General Meeting on 6 May 2016. Any Shares repurchased will be held in Treasury.

 

Due to the general illiquidity in trading of BrainJuicer's ordinary shares, in order for the Company to buy back ordinary shares, it will be purchasing materially in excess of the limit of 25 per cent. and/or 50 per cent. of average daily volume in the 20 trading days preceding the date of the purchase as is set out in the Code of Market Conduct and, as such, the Company would be deviating from the safe harbour set out in MAR 1 Annex 1 to the Code of Market Conduct. Should a repurchase exceed either the 25 per cent. or 50 per cent. levels, such repurchase is likely to represent a significant proportion of the daily trading volume.

 

John Kearon, Chief Executive Officer of the Company, intends to participate in the Buyback. The Buyback will be conducted conditional upon John's interest in the ordinary shares of the Company, and those deemed to be acting in concert with him, not increasing beyond the percentage of voting rights currently held.

 

The Company will make further announcements in due course following the completion of any purchase of ordinary shares pursuant to the Buyback.

 

The Company confirms it currently has no unpublished price sensitive information.

 

 

For further information, please contact:

BrainJuicer Group PLC

Tel: +44 (0)20 7043 1000

 

John Kearon, Chief Executive Officer

 

James Geddes, Chief Financial Officer

 

Canaccord Genuity Limited (Nomad)

Tel: +44 (0)20 7523 8000

Simon Bridges / Henry Fitzgerald-O'Connor / Emma Gabriel

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSJBMFTMBBJMBF
Date   Source Headline
31st Aug 202211:00 amRNSNotice of AGM
31st Aug 20227:00 amRNSDirectorate Change
31st Aug 20227:00 amRNSReview of strategic options
30th Aug 20226:00 pmRNSTransaction in Own Shares
19th Aug 20228:55 amRNSTransaction in Own Shares
3rd Aug 20225:45 pmRNSTransaction in Own Shares
2nd Aug 20223:45 pmRNSTransaction in Own Shares
29th Jul 20229:30 amRNSTransaction in Own Shares
26th Jul 20226:24 pmRNSTransaction in Own Shares
19th Jul 20224:00 pmRNSHolding(s) in Company
19th Jul 20223:00 pmRNSTransaction in Own Shares
18th Jul 20224:30 pmRNSTransaction in Own Shares
15th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20227:00 amRNSShare Buyback Programme
12th Jul 20227:00 amRNSQuarterly Trading Update
12th Jul 20227:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2022
30th Jun 20224:15 pmRNSHolding(s) in Company
30th Jun 20229:30 amRNSHolding(s) in Company
27th Jun 20223:00 pmRNSDirectorate Change
22nd Jun 20227:00 amRNSDistribution policy
6th Jun 20227:00 amRNSHolding(s) in Company
26th May 20221:15 pmRNSDirectorate Change
13th May 202212:15 pmRNSChange of Registered Office
27th Apr 20227:00 amRNSTrading Update
1st Apr 20222:00 pmRNSCompletion of Share Buyback Programme
25th Mar 20225:21 pmRNSTransaction in Own Shares
23rd Mar 20223:30 pmRNSTransaction in Own Shares
22nd Mar 20225:32 pmRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSUpdate re Stefan Barden
11th Mar 20226:00 pmRNSTransaction in Own Shares
11th Mar 20223:30 pmRNSHolding(s) in Company
4th Mar 20226:25 pmRNSTransaction in Own Shares
4th Mar 202210:15 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20224:15 pmRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTrading Update
21st Feb 20223:15 pmRNSTransaction in Own Shares
18th Feb 20225:31 pmRNSTransaction in Own Shares
16th Feb 20225:30 pmRNSTransaction in Own Shares
15th Feb 202210:15 amRNSTransaction in Own Shares
14th Feb 20225:02 pmRNSTransaction in Own Shares
11th Feb 20225:15 pmRNSTransaction in Own Shares
9th Feb 20223:45 pmRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTrading Update
4th Feb 202211:45 amRNSHolding(s) in Company
24th Jan 20225:50 pmRNSTransaction in Own Shares
21st Jan 20225:15 pmRNSTransaction in Own Shares
20th Jan 20225:15 pmRNSTransaction in Own Shares
12th Jan 202212:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.